Caris Life Sciences

Caris Life Sciences is a precision oncology company founded in 2008. It operates at the intersection of molecular science and artificial intelligence to develop and deliver cancer diagnostic and profiling solutions. Its work is centered on the oncology, healthcare, and precision medicine sectors.

The company's technical capabilities span molecular profiling, tumor profiling, whole genome sequencing, whole transcriptome sequencing, artificial intelligence, and blood-based cancer diagnostics. Its product portfolio includes MI Profile, a molecular profiling offering that provides comprehensive blueprints of each patient's cancer; MI Cancer Seek, a blood-based cancer diagnostic; and Caris ChromoSeq, which the company describes as the world's first whole genome and whole transcriptome sequencing solution.

Caris Life Sciences states that it is backed by a team of scientific and medical professionals and driven by innovation, compassion, and purpose.